WHITE PAPERS & CASE STUDIES

  • SynteractHCR Full-Service CRO Brochure

    SynteractHCR is a multinational clinical research organization, formed from the merger of Synteract with Harrison Clinical Research in 2013, which provides global, full-service clinical trial services. We have more than two decades of experience supporting biopharma companies in all phases of clinical development across multiple therapeutic areas. We customize programs that will deliver timely, high quality data to help you get to decision points faster, taking time and cost out of drug development.

  • Improve Accuracy And Efficiency In Data Collection For Mental-Health Evaluations And Assessments

    MedAvante is a global provider of centralized, expert psychological rating services to the pharmaceutical, biotechnology, and medical device industries.

  • Phase II Alzheimer's Case Study

    A double-blind, Phase II, placebo-controlled clinical trial to evaluate the safety and efficacy of a novel compound in subjects with mild to moderate Alzheimer’s disease.

  • Moving Towards An Electronic Environment In Clinical Trials

    With each passing year, clinical trials are becoming increasingly global. The business of product development is moving away from the traditional model in which studies are conducted primarily in the US – in fact, recent estimates indicate that within the next three years, up to 65 per cent of studies under FDA regulation will be conducted outside the US. A review of a US government clinical trials registry and of 300 published reports in major medical journals revealed that one third (157 of 509) of Phase III trials were being conducted entirely outside the US, with over half the study sites (13,521 of 24,206) used in these trials located overseas, many in eastern Europe and Asia.

  • Brochure: Norwich Clinical Services

    Norwich Clinical Services is a contract research organization that provides Bioanalytical Services, Pharmacovigilance and Clinical Research Programs to the pharmaceutical and biotech industries.

  • Optimizing Clinical Trial Enrollment: Same Day Turnaround Of Blood Chemistry For Eligibility

    Potential clinical trial participants and sponsors typically wait 2-3 days for lab results to determine eligibility. For the would-be participant every day that elapses could contribute to the loss of interest and increase the risk of losing a potential study subject for many reasons. By Paul S. Savuto, MS, MBA Blinded Diagnostics

More White Papers & Case Studies

SERVICES & PRODUCTS

CRISTal - Clinical Research Interactive Selection Tool

CRISTal is RDP Clinical Outsourcing’s proprietary software platform that facilitates the strategic identification of sites, as well as our highly experienced regional monitors.

Point Of Care Solutions For Pharmaceutical Clinical Trials
Blinded Diagnostics is a contract service organization specializing in same day lab test results using point-of-care diagnostic platforms to optimize patient enrollment testing, blinded studies, adaptive trials and remote patient testing.
Point Of Care: Neurological Testing
Blinded Diagnostics offers ambulatory EEG for neurological tests which are typically performed at the point of care
Point Of Care: Drug Abuse Testing
Point of care drugs of abuse tests include Methadone, Opiates, THC and Amphetamines for screening and has available results in minutes.
CNS Services

A leading western CRO in Russia, ClinStar offers invaluable experience to enhance your study execution, resulting in higher-quality results. We offer local regulatory, customs and logistical expertise as well as clinical teams that are therapeutically trained in CNS diseases.

CNS
We recognize one of the most important pieces of your outsourcing puzzle is a CRO’s therapeutic expertise. Theorem Clinical Research features experience in a variety of different major areas.
More Services & Products

NEWS

More News